Pharmaceutical products

Tender description

Invitation to offer for NHS National Framework for Generic Pharmaceuticals — Wave 12. Offer reference number: CM/PHG/17/5531 Period of Framework Agreement: the total maximum duration of the Framework Agreement to be no more than 48 months. Potential periods of call-offs under the framework agreement: Hospital only products: — DLS/DNE/DNW regions: 1.2.2020 to 31.1.2022 (24 months), — DLN/DCE/DSW regions: 1.2.2020 to 31.1.2021 (12 months), — oral products (100 %) all regions: 1.2.2020 to 28.2.2021 (13 months). Details of products, presentation sizes and volumes are within the tender document set. NHS National Generic Pharmaceuticals Wave 12 Offer reference number: CM/PHG/17/5531 Period of Framework Agreement: the total maximum duration of lot 1 of the Framework Agreement to be no more than 26 months. Potential periods of call-offs under the Framework Agreement: 1.2.2020 to 28.2.2021 (13 months). NHS National Generic Pharmaceuticals Wave 12 Offer reference number: CM/PHG/17/5531 Period of Framework Agreement: The total maximum duration of lot 2 to be no more than 48 months. Potential periods of call-offs under the Framework Agreement: 1.2.2020 to 31.1.2022 (24 months). NHS National Generic Pharmaceuticals Wave 12 Offer reference number: CM/PHG/17/5531 Period of Framework Agreement: the total maximum duration of lot 3 to be no more than 24 months. Potential periods of call-offs under the Framework Agreement: 1.2.2020 to 31.1.2021 (12 months).